Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors
Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors News provided by Share this article Share this article CONCORD, Mass., Feb. 9, 2021 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that Revitope Oncology is extending its collaboration to develop a systems pharmacology model for Revitope's dual antigen targeting TwoGATE™ platform for soli...
Source: prnewswire.com